ERBB2 and breast cancer: Moreover, consistently with previous findings, the Triple Negative BC molecular subgroup showed the highest levels of miR-210-3p expression, followed by Luminal B tumours, whereas Luminal A and HER2-amplified tumours showed the lowest expression levels.